Showing all 6 results
ProteqFlu-Te suspension for injection for horses
One dose contains
Influenza A/equi-2/Ohio/03 [H3N8] recombinant Canarypox virus (vCP2242) ≥ 5.3 log10 FAID50;
Influenza A/equi-2/Newmarket/2/93 [H3N8] recombinant Canarypox virus (vCP1533) ≥ 5.3 log10 FAID50;
Clostridium tetanitoxoid ≥ 30 IU. Adjuvant: Carbomer.
Primary vaccination course:
First injection from 5–6 months of age,
Second injection 4–6 weeks later.
5 months after primary vaccination course
In case of increased infection risk or insufficient colostrum intake, an additional initial injection of ProteqFlu-Te can be given at the age of 4 months followed by the full vaccination programme above
Flunixin meglumine 50mg/ml
Rapid & strong anti-inflammation (NSAID), assist recovery, eg mastiti-metritis-agalactia， fever due to respiratory diseases, etc
2ml per 50 kg body weight